OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.1 weeks; Submission to Acceptance: 17.0 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017
Open Access Original Research

About Cryptic Acrocentric Pericentromeric Abnormalities in Infertile

Seria Tsan , Stefanie Kankel , Niklas Padutsch , Luisa Person , Monika Ziegler , Ahmed Al-Rikabi , Anja Weise , Kristin Mrasek , Thomas Liehr *

Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Am Klinikum 1, D-07747 Jena, Germany

* Correspondence: Thomas Liehr

Academic Editor: Joep Geraedts

Collection:  Genetic Testing

Received: April 16, 2021 | Accepted: August 16, 2021 | Published: August 25, 2021

OBM Genetics 2021, Volume 5, Issue 3, doi:10.21926/obm.genet.2103135

Recommended citation: Tsan S, Kankel S, Padutsch N, Person L, Ziegler M, Al-Rikabi A, Weise A, Mrasek K, Liehr T. About Cryptic Acrocentric Pericentromeric Abnormalities in Infertile. OBM Genetics 2021; 5(3): 135; doi:10.21926/obm.genet.2103135.

© 2021 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Abstract

Cryptic balanced chromosomal aberrations can be an underlying cause of infertility. In 2003 Cockwell and coworkers highlighted the relevance of euchromatic pericentric regions of acrocentric chromosomes that may be a yet ignored genomic region hosting cryptic rearrangements. Here we offer the first follow-up study to further explore this idea. Two specific molecular cytogenetic probe sets were established to elucidate such cryptic rearrangements together with chromosomal heteromorphisms of acrocentric centromeres. In 28 infertile couples and 20 controls, the rate of centromeric heteromorphisms was almost comparable in both groups and one heteromorphism was noted in ~30% of the cases, and two heteromorphisms in ~15% and three heteromorphisms 5%. However, none of the studied groups revealed any cryptic euchromatic pericentromeric abnormalities of the acrocentrics. Nonetheless, in parallel an infertile case with an inv(13)(p12q12.1?2) was uncovered, being not part of the systematically studied group of infertile. As unbalanced products of meiosis with such or similar karyotypes can potentially contribute to abortions, the existence of rare, cryptic pericentromeric euchromatic abnormalities in the acrocentrics thus needs to be still expected in banding cytogenetic diagnostics. Accordingly, this study reflected that suspicious acrocentric short arms in infertile need special attention and further characterization by fluorescence in situ hybridization.

Keywords

Cryptic abnormalities; acrocentric chromosomes; infertile; molecular cytogenetics

1. Introduction

Gross and subtle chromosomal aberrations are known to indulge in adverse consequences for the carriers in their ability to reproduce. Therefore to rule out these possibilities, infertile patients are routinely examined by banding and molecular cytogenetics. Moreover, repeated and/or early abortions in infertile couples can result from gonosomal numerical and/or structural alterations, especially balanced chromosomal rearrangements [1]. The latter may be detected by banding cytogenetics, i.e., characterizable as gross balanced translocations, inversions, insertions, complex rearrangements, or the presence of supernumerary marker chromosomes [1,2,3]. Also, in such cases, fluorescence in situ hybridization (FISH) is recommended to screen for subtelomeric rearrangements that are invisible in banding cytogenetics [4]. Furthermore, mutation in AZF genes on the Y-chromosome, as well as CFTR-gene mutations in chromosome 7 can contribute to male infertility [5].

In 2003 Cockwell and coworkers [6] proposed the presence of other cryptic rearrangements, besides subtelomeric in the euchromatic pericentric regions of acrocentric chromosomes. They reported, a substantial part of infertile couples, specifically those with repeated abortions, may be the carrier of (un)balanced translocations involving chromosomes 13, 14, 15, 21, and 22 with breakpoints in euchromatic proximal long arms. They picked up two times a der(15)t(13;15)(q1?1;q11.2) karyotype among 50 chromosomally normal couples (i.e., 100 persons). Furthermore, three cases were documented with distinct chromosomal heteromorphisms, such as loss of subband 22p11.2 (indicated by loss of D22Z4 sequences) and presence of a der(21)t(Y;21)(q12;p11.2). Even though “a prospective study to include many more couples in which full family studies will be carried out” was announced by the authors [6], to the best of our knowledge, there was no subsequent follow-up study published.

To characterize chromosomal centromeric heteromorphisms of acrocentric short arms, and at the same time to screen for translocations involving the proximal part of acrocentric chromosomes’ long arms, we developed two specific probe sets and tried to close this gap. This probe set was applied in 28 infertile couples and 20 controls studied cytogenetically for other reasons. Parallel to this, one patient, with a cryptic chromosomal rearrangement in the euchromatic pericentromeric region of chromosome 13, not included in the systematic study, was picked up.

2. Materials and Methods

2.1 Patients

Standard procedures were followed to prepare the peripheral blood for cytogenetic assessment [7]. Overall, 28 infertile couples, i.e. 56 patients, 20 controls investigated cytogenetically in parental studies, and one additional patient with infertility (Table 1) were evaluated by molecular cytogenetic probe sets as described below. All patients were phenotypically normal. For the majority of infertile patients molecular genetic analyses were conducted to exclude males mutations in CFTR- and AZF genes (see Table 1); these studies were done based on the literature using multiplex ligation-dependent probe amplification (MLPA – kit SALSA® MLPA® probemix P091 CFTR - MRC Holland) [8] and multiplex-polymerase chain reaction (PCR) detecting 3 to 4 loci in AFZc and AFZa and AZFb genes [9].

Table 1 Results obtained from the study population with an in banding cytogenetics normal karyotype. abbreviations: C = control; d. by = detected by; E = extra case; F = female; FISH = fluorescence in situ hybridization; I = infertile; M = male; n.a. = not applicable; n.t. = not tested; rear. = rearrangement; - = none detected.

In accordance with the local legislation and institutional requirements, ethical review and approval were not required for the present study on human participants as data presented here were obtained during routine diagnosis, which was supported by informed consent from patients.

2.2 Molecular Cytogenetics

FISH was executed following standard procedures [10]. To address the problem in the present study, two probe sets covering centromeres and centromere-near regions of all acrocentric chromosomes were developed. The probe sets were deduced from chromosome-specific previously reported subcentromere-specific multicolour-FISH (subcenM-FISH) [10] and cenM-FISH probes sets [11]. Figure 1 illustrates the schemes of the two acrocentrics oriented probe sets together with corresponding typical results in normal chromosome sets. Besides centromeric probes obtained from Prof. Mario Rocchi (Bari, Italy), commercially available centromere-near bacterial artificial chromosome (BAC) probes were also applied, as specified in Figure 1. These probes were labeled by SpectrumGreen, SpectrumOrange, SpectrumRed, Dietylaminocoumarin, and biotin; the latter was detected by avidin-Cyanin5 (for labeling, see also [12]). A homemade probe specific for all acrocentric short arms was also applied in the case of E-1 F [12]. For each probe set and patient, 20 metaphases were evaluated using a fluorescence microscope (Axioplan 2 MOT, Zeiss, Jena, Germany) equipped with appropriate filter sets to discriminate between a maximum of five fluorochromes and the counterstain DAPI (diaminophenylindol). Isis imaging system (MetaSystems, Altlussheim, Germany) was employed for image capturing and processing.

Click to view original image

Figure 1 Probe sets 1 and 2 are illustrated schematically in (A), and the typical FISH results obtained after sorting all acrocentric chromosomes in a partial karyogram are represented in (B). Localization of the probes and their names are denoted in parts A beside their corresponding idiograms.

3. Results

3.1 Probe Sets

On applying the two probe sets (shown in Figure 1) separately on the 20 control persons, evaluable signal patterns were revealed reliably. Thereafter, the probe set was applied successfully in the 28 infertile couples with 56 individuals. Probe set 1 was solely applied to patient E-1, who was studied separately by FISH.

3.2 FISH-Results

Table 1 summarizes the FISH results. Cryptic acrocentric pericentromeric abnormalities involving euchromatin could be observed in neither any of the 20 controls nor in any of the 56 tested infertile patients (Table 1). However, while performing this study, a corresponding half-cryptic acrocentric pericentromeric abnormality was detected in one case with unexplained infertility: here a karyotype 46,XX,inv(13)(p12q12.1?2) was found (Figure 2).

Click to view original image

Figure 2 Probe set 1 was employed in the case of E-1 F for chromosome 13 and accompanied by a homemade probe for all acrocentric p-arms. Thus, the inv(13)(p12q12.1?2) could be clearly characterized.

Furthermore, FISH results (Table 1) revealed zero to three centromeric heteromorphisms per case. The rates of heteromorphism in infertile and non-infertile were as follows: no heteromorphism was detected in 33/56 (59%) and 8/20 (40%) cases, one heteromorphism was observed in 14/56 (~25%) and 7/20 cases (~35%), respectively; and there were two heteromorphisms in 7/56 (~12%) and 4/20 (~20%), and three heteromorphisms in 2/56 (~4%) and 1/20 (~5%) cases, each. Heteromorphisms observed were weaker or (almost) absent centromeric signals on a chromosome (= cen13h-, cen14hg-, cen15h-, cen21h-, cen22h-), or massively stronger than to be expected, as witnessed in the case for the chromosome 13 (cen13h+).

Figure 3 summarizes the distribution of heteromorphisms per chromosome. Interestingly, compared to the control group, the frequency of heteromorphisms in chromosome 15 was found to be lower in the infertile group, while the other ones – considering the relatively small case numbers in both groups – were more or less equal.

Click to view original image

Figure 3 Distribution of heteromorphisms per chromosome is represented in absolute numbers (A) and in relation to each other (B). Abbreviations: het = heteromorphism; inf = infertile; n = number of cases; # = chromosome.

4. Discussion

In 2003 Cockwell and coworkers [6] reported that around 2-5% of the infertile or persons in couples with repeated abortions might be carriers of a cryptic pericentromeric euchromatic abnormality in the acrocentrics. These statistics were derived from a pilot study with 100 participants, in which three had a chromosomal heteromorphism and two an unbalanced der(15)t(13;15).

Till date, ~550 chromosomal heteromorphisms are known in humans [13]. These include loss or diminishing of subband 22p11.2 (indicated by loss of D22Z4 sequences) and derivatives of all 5 acrocentric chromosomes with Yq12 sequences at subband p11.2 [14], as both reported in an earlier study [6]. Moreover, as documented in the present study, comparable rates of chromosomal heteromorphisms for alphoid sequences are obtained among infertile and non-infertile patients [13]. All of these chromosomal heteromorphisms are still suggested to be mostly irrelevant copy number changes of heterochromatic repetitive DNA-stretches. However, such alphoid DNA is also known to be expressed as non-coding RNA in embryogenesis and tumor cells [15].

The present study failed to provide any hint on cryptic pericentromeric euchromatic abnormalities in the acrocentrics. Though this preliminary work encompasses a small study population, it is also noteworthy that, to the best of our knowledge, since 2003, no cryptic pericentromeric euchromatic abnormality for the acrocentrics has been reported in the literature. Nonetheless, being rare, case E-1 F with inv(13)(p12q12.1?2) supports the existence of such incidences. This rationalizes the necessity to explore the acrocentric short arms and pericentric regions, as unbalanced products of meiosis are possible, which potentially could result in abortions.

5. Conclusions

Even though being rare, cryptic pericentromeric euchromatic abnormality in the acrocentrics needs to be considered in banding cytogenetic diagnostics. It is highly recommendable to investigate the suspicious short arms of acrocentrics in cytogenetic preparations of infertile persons by FISH. Furthermore, as recently highlighted, proper elucidation of the etiology of chromosomal rearrangements on cytogenetic bases often aid in the correct interpretation of the results of modern high throughput diagnostic schemes [16]. Accordingly, data from molecular karyotyping of abortions with centromere-near euchromatic copy number variations of acrocentric chromosomes should also indulge in parental follow-up studies for cryptic inversions, translocations, or other rearrangements by cytogenetics and FISH.

Acknowledgments

Case E-1 F was provided for molecular cytogenetic diagnostics from Drs. Hentze and Louis, Heidelberg, Germany.

Author Contributions

TL set up study design. AW performed the banding cytogenetic analyses. AA-R did probe set development. ST, SK, NP, LP, MZ, and AA-R did FISH-experiments and pre-evaluation. KR did molecular genetic analyses. Final evaluation of FISH-results was done by ST and MZ. TL led together all data and did final assessments and drafted and wrote the paper. All authors read and approved final version of the paper.

Competing Interests

The authors have declared that no competing interests exist.

References

  1. Mau-Holzmann UA. Somatic chromosomal abnormalities in infertile men and women. Cytogenet Genome Res. 2005; 111: 317-336. [CrossRef]
  2. Manvelyan M, Schreyer I, Höls-Herpertz I, Köhler S, Niemann R, Hehr U, et al. Forty-eight new cases with infertility due to balanced chromosomal rearrangements: Detailed molecular cytogenetic analysis of the 90 involved breakpoints. Int J Mol Med. 2007; 19: 855-864. [CrossRef]
  3. Liehr T, Hamid Al-Rikabi AB. Impaired spermatogenesis due to small supernumerary marker chromosomes: The reason for infertility is only reliably ascertainable by cytogenetics. Sex Dev. 2018; 12: 281-287. [CrossRef]
  4. Knight SJ, Flint J. Perfect endings: A review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000; 37: 401-409. [CrossRef]
  5. Kamiński P, Baszyński J, Jerzak I, Kavanagh BP, Nowacka-Chiari E, Polanin M, et al. External and genetic conditions determining male infertility. Int J Mol Sci. 2020; 21: 5274. [CrossRef]
  6. Cockwell AE, Jacobs PA, Beal SJ, Crolla JA. A study of cryptic terminal chromosome rearrangements in recurrent miscarriage couples detects unsuspected acrocentric pericentromeric abnormalities. Hum Genet. 2003; 112: 298-302. [CrossRef]
  7. Weise A, Liehr T. Pre- and postnatal diagnostics and research on peripheral blood, bone marrow chorion, amniocytes, and fibroblasts. In: Fluorescence in situ Hybridization (FISH) – application guide. 2nd ed. Berlin, Heidelberg: Springer; 2017. p. 171-180. [CrossRef]
  8. Svensson AM, Chou LS, Miller CE, Robles JA, Swensen JJ, Voelkerding KV, et al. Detection of large rearrangements in the cystic fibrosis transmembrane conductance regulator gene by multiplex ligation-dependent probe amplification assay when sequencing fails to detect two disease-causing mutations. Genet Test Mol Biomarkers. 2010; 14: 171-174. [CrossRef]
  9. Gholami D, Jafari-Ghahfarokhi H, Nemati-Dehkordi M, Teimori H. Y chromosome microdeletions frequency in idiopathic azoospermia, oligoasthenozoospermia, and oligospermia. Int J Reprod Biomed. 2017; 15: 703-712. [CrossRef]
  10. Liehr T, Mrasek K, Weise A, Dufke A, Rodríguez L, Martínez Guardia N, et al. Small supernumerary marker chromosomes--progress towards a genotype-phenotype correlation. Cytogenet Genome Res. 2006; 112: 23-34. [CrossRef]
  11. Nietzel A, Rocchi M, Starke H, Heller A, Fiedler W, Wlodarska I, et al. A new multicolor-FISH approach for the characterization of marker chromosomes: Centromere-specific multicolor-FISH (cenM-FISH). Hum Genet. 2001; 108: 199-204. [CrossRef]
  12. Mrasek K, Heller A, Rubtsov N, Trifonov V, Starke H, Claussen U, et al. Detailed Hylobates lar karyotype defined by 25-color FISH and multicolor banding. Int J Mol Med. 2003; 12: 139-146. [CrossRef]
  13. Liehr T. Cases with heteromorphisms [Internet]. ChromosOmics–Database; 2021 [cited date 2021 April 16]. Available from: http://cs-tl.de/DB/CA/HCM/0-Start.html.
  14. Smith A, Fraser IS, Elliot G. An infantile male with balanced Y;19 translocation: Review of Y; autosome translocations. Ann Genet. 1979; 22: 189-194.
  15. Rizzi N, Denegri M, Chiodi I, Corioni M, Valgardsdottir R, Cobianchi F, et al. Transcriptional activation of a constitutive heterochromatic domain of the human genome in response to heat shock. Mol Biol Cell. 2004; 15: 543-551. [CrossRef]
  16. Hochstenbach R, Liehr T, Hastings RJ. Chromosomes in the genomic age. Preserving cytogenomic competence of diagnostic genome laboratories. Eur J Hum Genet. 2021; 29: 541-552. [CrossRef]
Newsletter
Download PDF Download Citation
0 0

TOP